« Back to Record
Van Laethem, J.-L., Borbath, I., Prenen, H., Geboes, K., Lambert, A., Mitry, E., Cassier, P. A., Blanc, J. F., Pilla, L., Batlle, J. F., Garrote, M. R., Pazo-Cid, R. A., Gallego, I., Smith, K. E., Ellmark, P., Pico de Coaña, Y., Ambarkhane, S. V., & Macarulla, T. (2024). Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study. Lancet oncology, 25(7), 853-864. doi:10.1016/S1470-2045(24)00263-8
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/376773



